Isabelle Wilson
MSc, BSc (Hons)
School of Medicine and Population Health
Research Assistant/Medical Statistician
isabelle.wilson@sheffield.ac.uk
Barber House
Full contact details
Isabelle Wilson
School of Medicine and Population Health
Barber House
Sheffield
S10 2HQ
School of Medicine and Population Health
Barber House
Sheffield
S10 2HQ
- Profile
-
I joined the CTRU in October 2022 as part of my NIHR pre-doctoral fellowship to research response adaptive randomisation, a type of adaptive design. After finishing this in March 2024, I became a research assistant/medical statistician within the CTRU.
I received a first-class BSc (Hons) in Mathematics at the University of Nottingham in August 2021. Following this, I began the MSc in Statistics with Medical Applications at the University of Sheffield. My dissertation focused on sample size considerations for short-term, length-of-stay outcomes.
- Qualifications
-
- MSc in Statistics with Medical Applications at the University of Sheffield.
- BSc (Hons) in Mathematics at the University of Nottingham.
- Research interests
-
- Response adaptive randomisation.
- Adaptive designs.
- Publications
-
Journal articles
- Mesenchymal stromal cell infusions of umbilical cord-derived mesenchymal stromal cells in children with recessive dystrophic epidermolysis bullosa (MissionEB): a randomised, double-blind, placebo controlled, crossover, phase 3 trial with an internal phase 1 dose de-escalation phase. EClinicalMedicine. View this article in WRRO
- Response adaptive randomisation in clinical trials: Current practice, gaps and future directions.. Statistical Methods in Medical Research, 34(9), 1851-1874. View this article in WRRO
- A Tutorial on Value-Based Adaptive Designs: Could a Value-Based Sequential 2-Arm Design Have Created More Health Economic Value for the Big CACTUS Trial?. Value in Health, 27(10), 1328-1337.
- Mesenchymal stromal cell infusions of umbilical cord-derived mesenchymal stromal cells in children with recessive dystrophic epidermolysis bullosa (MissionEB): a randomised, double-blind, placebo controlled, crossover, phase 3 trial with an internal phase 1 dose de-escalation phase. EClinicalMedicine. View this article in WRRO
- Grants
-
- NIHR Pre-Doctoral Fellowship Award. NIHR (NIHR302738). Lead Applicant. £66,757.
- MSc Scholarship. Amgen. Lead Applicant. £11,500.